Background Brain natriuretic peptide (BNP) is increasingly recognized as a practical, reliable and accurate indicator of left ventricular function and may have an important prognostic role in determining outcome following myocardial infarction and heart failure.
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The role of the predominantly ventricular-derived BNP in the body's physiological defence against hypertension and plasma volume overload is achieved through its potent natriuretic, diuretic and vasorelaxant activity. In addition to left ventricular dysfunction, BNP may also be raised in the presence of ventricular hypertrophy and increased heart rate. 2 The issue of BNP stability in vitro has been veri¢ed by several studies, which makes it a potentially valuable and practical biochemical marker of underlying cardiac function, both in the hospital setting and in the community. 3, 4 While investigating the clinical value of BNP in patients referred for dobutamine -stress echocardiography we also noted that BNP concentrations appeared to increase with age. We studied 60 patients (39 males) aged 32^83 years referred for evaluation of possible reversible myocardial ischaemia. All patients presented with symptoms of chest pain with or without exertional breathlessness. The left ventricular ejection fraction (LVEF) in all 60 patients was 450% on echocardiographic assessment, before dobutamine stress, using parasternal short and long axis, apical two-and four-chamber views. None of the patients had evidence of left ventricular hypertrophy, left atrial enlargement, cardiomyopathy, valvular lesions, regional wall motion abnormalities or ischaemic changes on 12-lead ECG. All were in sinus rhythm at the time of their presentation and assessment.
Two patients (3¢3%) were con¢rmed to have an obstructive defect on subsequent pulmonary function tests. Five patients (8¢3%) were on b-blockers, one (1¢7%) was on an ACE inhibitor and none were on diuretic therapy. Only three (5%) of the 60 patients had renal function outside the upper limit of our normal reference range (creatinine value 120 mmol/L). These patients were aged 50, 69 and 75 years, with respective creatinine values of185, 268 and 230 mmol/ L. The study was approved by our local ethics committee and written, informed consent was obtained in all cases.
All patients had been in the supine position for a minimum of 10 min before undergoing dobutamine Short Report stress and prior to the resting heart rate being recorded and blood collected for BNP analysis. A 3 mL blood sample was taken into an EDTA tube, to which 90 mL of the protease inhibitor Trasylol was added, and stored at 48C. Samples were centrifuged at 1700 g for 15 min and stored at 7708C prior to batch analysis using a solid-phase immunoradiome tric assay (Shionoria, Cis UK Ltd, Bucks, UK).
The mean (+SD) patients' resting heart rate was 74 (+12) beats/min. Mean BNP concentrations were 25¢5 (+17¢5) ng/L. BNP concentrations were plotted against patients' ages ( Fig. 1) and the data subjected to Spearman's rank correlation analysis. BNP concentrations (ng/L) showed a signi¢cant linear correlation with age in years: r sˆ0 ¢53 (95% CI 0¢25^0¢73), P50 ¢0001.
The observation that plasma natriuretic peptide concentrations rise with the patient's age is well established for both ANPand BNP. 5 Our own observation of a linear relationship of BNP concentrations with patient's age in the presence of normal left ventricular function is important, and suggests the need for consideration of age when interpreting BNP concentrations in the population. In our cohort, 32 (53%) patients with structurally and functionally normal left ventricles could have been interpreted as`abnormal' based on BNP concentrations 420 ng/L (mean+2¢5 SD).
This relationship with age may re£ect a gradation of ventricular function within a group of`normals', where the LVEF may be more accurately quanti¢ed by a sensitive biochemical marker rather than the human eye. Diastolic ventricular dysfunction is increasingly recognized in the older population. Although we did not speci¢cally determine or document this variable in our population of patients in this study, we accept that its presence may in£uence BNP concentrations and that the assessment of diastolic LV function should be included in a larger controlled trial.
An alternative or concomitant source of BNP is the central nervous system. Progressive neuronal degeneration occurs as part of the normal ageing process and may result in a proportionally greater central production and/or release of BNP. Impairment of renal function in the elderly could explain the relationship between BNP and age, but only 5% of our patients had abnormal creatinine values and we were unable to demonstrate any correlation between renal function and BNP concentrations or age, respectively.
Although we observed a clear relationship between BNP concentrations and age in structurally and functionally normal ventricles, this would be di¤cult to demonstrate in abnormal, dilated or hypertrophied hearts. In our assessment of a total of 11 patients with LVEF 550% BNP concentrations ranged from 33 ng/L to 865 ng/L, making it impossible to discern accurately an age relationship within a multivariate model that included left ventricular function. It would be interesting to see whether such a relationship could be validated in larger controlled trials that included both normal and abnormal hearts.
BNP is increasingly recognized as a simple, practical test to help in the assessment of left ventricular function. It has been reported to provide a reliable and accurate indication of left ventricular function in certain patient populations, and may have an important prognostic role in determining outcome following myocardial infarction and in congestive cardiac failure. 1, 6, 7 The clinical diagnosis of heart failure in primary care is fairly unreliable, with only 25^50% of patients thus diagnosed being con¢rmed as having cardiac dysfunction on subsequent cardiological evaluation. 8 BNP can be measured as a simple, stable and coste¡ective blood test, which makes it an ideal candidate for use in hospitals and by community GPs to aid the assessment and monitoring of cardiac function. This would allow more appropriate cardiological referrals and, in turn, enable a more e¤cient use of echocardiography services.
It is therefore vital that we are aware of the existence of a potentially independent relationship of BNP concentration to age. Our ¢ndings would support the need for larger, controlled trials to investigate such an association.
